Abstract
Calcium- and integrin-binding protein 2 (CIB2) plays a crucial role in mechanoelectrical transduction (MET) in cochlear hair cells, particularly in modulating the function and localization of the core components of MET channels TMC1/2. CIB2, along with its homolog CIB3, interacts with TMC1/2 through two distinct sites. Here, our study unveils CIB2/3’s role as a calcium sensor in its interaction with TMC1. Utilizing X-ray crystallography, we elucidate the high-resolution structure of the mammalian CIB2-TMC1 complex. Structural analyses reveal that cation-bound CIB2 forms a negatively charged surface that aligns with a positively charged surface on the TMC1 N-terminus. Moreover, our data suggest that Ca²⁺ modulates CIB2’s interaction with both the N-terminal domain and the loop 1 region of TMC1, and that Ca²⁺-bound CIB2 is capable of simultaneously binding to both regions of TMC1. Critically, we examine pathogenic variants of CIB2 associated with hearing loss, discovering that these variants have differential impacts on CIB2’s interactions with TMC1’s dual binding sites, displaying diminished calcium-binding affinities for several of these CIB2 mutations. These findings provide a deeper understanding of the molecular mechanisms underlying CIB2 function and its implications in hearing loss, offering potential avenues for therapeutic interventions in deafness.
Similar content being viewed by others
Introduction
In mammals, the perception of sound is initiated through mechanoelectrical transduction (MET) in cochlear hair cells. These cells, embedded within the organ of Corti, are characterized by their apical stereocilia, arranged in a staircase-like formation1. Crucial to MET is the role of specialized channels located at the tips of these stereocilia, responsible for transducing mechanical stimuli into electrical signals. Identifying the molecular constituents of these MET channel complex has been a focal point of auditory research. TMC1 and TMC2, integral membrane proteins situated at the tip of the shorter-row stereocilia, have been identified as principal components of these channels2,3,4. Their significance is further underscored by findings revealing their pore-forming abilities and high Ca²⁺ permeability5,6,7, and the association of specific TMC1 mutations with hereditary deafness8.
The functionality of MET channels is intricately regulated by auxiliary subunits, among which Calcium- and integrin-binding protein 2 (CIB2) plays a pivotal role. This EF-hand protein, capable of binding both Mg²⁺ and Ca²⁺, is predominantly expressed in cochlear hair cells9,10,11, and reported to interact with the N-terminal cytoplasmic region of TMC1/TMC29,12,13. Its importance is further underscored by the significant morphological defects in stereocilia and the association of CIB2 mutations with non-syndromic deafness9,14. Alongside its homolog CIB3, CIB2 is instrumental in regulating the transport and localization of TMC1 within stereocilia15. Recent studies have elucidated the interaction of CIB3 with TMC1, identifying a novel CIB-binding site within TMC1’s first cytoplasmic loop between transmembrane domain 2 and 315. Moreover, recent studies provided evidences that Piezo1 and Piezo2 form functional units capable of generating mechanoelectrical transduction (MET) currents. These units have been shown to interact with both mouse TMC1/TMC2 and CIB2, thereby suggesting that Piezo may constitute a part of the MET channel complex16.
Further insights into the CIB2-TMC interaction have been garnered from structural analyses using cryo-electron microscopy (cryo-EM) with the endogenously purified C. elegans TMC-1 and TMC-2 complex17,18. The findings from these studies have highlighted two distinct binding sites for CALM-1 on TMC-1, consistent with previous biochemical and structural findings9,15. However, the structural and mechanistic nuances of the CIB2-TMC1 interaction in mammals remain to be fully elucidated. This gap in understanding is due in part to the multifunctional nature of nematode TMC1, which exhibits diverse roles across various neuronal and muscular systems, such as functioning in mechanosensation in OLQ neurons, as a pH sensor in ASH neurons, and as a leak channel in HSN neurons and vulval muscles12,19,20. Therefore, the mechanistic details and structural basis of mammalian CIB2/TMC1 interaction have remained poorly understood to date, and a comprehensive understanding of the mammalian CIB2-TMC1 interaction, particularly from a structural perspective, is crucial for advancing our knowledge of MET processes and their implications in auditory function and dysfunction.
In this study, we meticulously examined the binding and structural interactions between TMC1 and CIB2. Our biochemical assays revealed that the 86-136 amino acid segment within the TMC1’s N-terminus is crucial for its robust interaction with both CIB2 and CIB3. We successfully resolved the high-resolution crystal structure of the mammalian CIB2-TMC1 complex, offering unprecedented insights into this interaction. The structural analyses highlight that electrostatic interactions and hydrogen bonding predominantly facilitate the complex formation, with hydrophobic interactions providing additional stabilization. Significantly, our findings also reveal a critical role for Ca²⁺ in the regulation of CIB2-TMC1 interaction, as elevated binding affinity between Ca²⁺-bound CIB2 and the N-terminus of TMC1. Interestingly, in the absence of Ca²⁺, no interaction was observed between CIB2 and the loop 1 region of TMC1. This disparity underscores the distinct nature of the two CIB2-binding sites within the CIB2-TMC1 complex. Furthermore, we evaluated several CIB2 deafness-related mutations and observed that these variants affected the binding to TMC1 differentially, coupled with a diminished Ca²⁺ binding affinity. These results collectively contribute valuable insights into the role of calcium ions in the formation of the MET complex, thereby advancing our understanding of the molecular mechanisms underlying mechanotransduction in the mammalian inner ear.
Results
Characterization of the CIB2-TMC1 interaction
The mammalian calcium- and integrin-binding protein family comprises four members, known as CIB1-421. CIB2 has been identified as the closest homolog to CIB3 (Supplementary Fig. 1a, b). Previous studies have revealed that a segment within the N-terminal cytoplasmic region of TMC1 serves as the binding domain for CIB29,12,13. We first systematically confirmed and delineated the specific interacting fragments of human TMC1 binding to full-length human CIB2 using isothermal titration calorimetry (ITC) assays with highly purified proteins. The results unequivocally established that the region encompassing residues 86–136 of human TMC1, denoted as “CBD-1” (CIB binding domain-1), is not only essential but also sufficient for binding to CIB2 (Fig. 1a, b, d). Notably, three fragments including 105–136, 116–136, and 86–116 exhibited no binding to CIB2 (Fig. 1b, Supplementary Fig. 2a–c). CIB2 exhibited binding to the 95-136 fragment of TMC1 with a dissociation constant (Kd) of approximately 4.6 μM, showing a 14-fold weaker affinity compared to the longer TMC1 CBD-1 (Fig. 1b, Supplementary Fig. 2d). Moreover, we utilized analytical gel filtration chromatography (AGFC) coupled with a static light scattering assay to ascertain the binding ratio between CIB2 and TMC1 CBD-1. The results revealed that both CIB2 and TMC1 CBD-1 exist as monomers, forming a complex with a 1:1 binding stoichiometry (Fig. 1c).
a Schematic diagram showing the domain organizations of CIB2 and TMC1. In this drawing, the interactions between CIB2 and TMC1 are indicated by two 2-way arrows. The CIB2 binding domain of TMC1 are highlighted in indigo and cyan. b ITC-based mapping of the CBD-1 domain in the TMC1 N-terminal region. The complete TMC1CBD-1 identified is highlighted in indigo. N.D. refers to not detectable. c Analytical gel filtration chromatography analysis coupled with static light scattering analysis of CIB2 1-187 (orange line), TMC1CBD-1 (pastel blue line), and the CIB2-TMC1 complex (red line), indicating that CIB2 and TMC1 form a stable 1:1 complex in solution. d ITC-based measurement of the binding affinity of CIB2 1-187 with TMC1CBD-1. The Kd error is the fitting error obtained using one-site binding kinetics model in Origin 7.0 to fit the ITC data. e The measured binding affinities between CIB family proteins and TMC1CBD-1 from ITC-based binding assays.
Subsequent ITC assays were conducted to evaluate the binding affinities between TMC1 CBD-1 and all members of the CIB family (Fig. 1e). The experiments demonstrated a robust binding between TMC1 and CIB2 and CIB3, while a notably weak interaction was observed with CIB1 and no binding was detected with CIB4 (Fig. 1d, e, Supplementary Fig. 3a–c). AGFC assays further revealed the interaction between CIB3 and TMC1, with CIB3 existing in heterogeneous states (Supplementary Fig. 3d). Consolidating this data, we inferred that the direct interaction between TMC1 and CIB2 was marginally stronger than that with CIB3. Taken together, these findings underscore a robust interaction between CIB2 and TMC1, with the residues 86–136 of TMC1 mediating this interaction in a 1:1 binding ratio.
Overall crystal structure of CIB2 in complex with TMC1CBD-1
To elucidate the assembly mechanisms of the mammalian CIB2-TMC1 complex, we sought to crystallize the protein complex using different versions of complex preparations including mixing the two proteins at a 1:1 ratio or creating fusion proteins. Through comprehensive screening, we determined the crystal structure, in which TMC1CBD-1 was C-terminally fused to full-length CIB2. We resolved the complex structure to a 2.4 Å resolution using molecular replacement (Fig. 2, Table 1). In line with our biochemical data, the final structure model encompasses amino acids 3 to 187 of CIB2 and 86 to 127 of TMC1.
Ribbon representation model showing the overall structure of the CIB2-TMC1CBD-1 complex. In this drawing, CIB2 is shown in orange, and TMC1 is shown in light blue, the fusion linker between CIB2 and TMC1 is shown in pink. Mg2+ are shown in gray. CIB2 contains 9 α-helical domains, denoted by α1-α9. TMC1CBD-1 contains 2 α-helices, denoted by αA and αB. The interface mediating the CIB2-TMC1 complex formation involves the α1 and α5 helices of CIB2, as well as the loop that links the α1 and α2 helices, all of which engage in the interactions with TMC1. The coordinates and structure factors of the CIB2 and TMC1 complex have been deposited to the Protein Data Bank under the accession code number 8XOQ.
In this structure, CIB2 adopts a superhelical fold with four EF-hands. Notably, only the third and fourth EF-hands of CIB2 are functional in cation response (Fig. 2). This configuration closely resembles its homologous proteins of CIB1 and CIB315,21. Interestingly, under calcium conditions (10 mM CaCl2) used during purification and magnesium conditions (200 mM MgCl2) used in the crystallization solution, we observed magnesium ions (Mg2+) binding to EF3 and EF4, rather than calcium ions (Fig. 2, Supplementary Fig. 4). The measurement results indicate that the distance between cation and the ligating oxygen atoms is approximately 2 Å in CIB2 EF-hand structure, which aligns with the typical range for Mg2+, and the distance for Ca2+ is found to be larger22,23. This preference for Mg2+ may be attributed to the inherently higher binding affinity of Mg2+ compared to Ca2+ for CIB224,25. The interface between CIB2 and TMC1 comprises the α1-helix, α5-helix, and loop connecting the α1 and α2 helices of CIB2, which interact with TMC1 (Fig. 2). TMC1 anchors via two α-helices - an N-terminal αA extending over 23 residues and a C-terminal αB comprising 13 residues, linked by a 6-residue connector (amino acids 108-113).
Detailed structure characterization at the CIB2-TMC1CBD-1 interface
Electrostatic potential analysis revealed a negatively charged central pocket on the surface of CIB2, corresponding to its binding site with TMC1 (Fig. 3a). Subsequent structural investigations indicated that the CIB2-TMC1CBD-1 interface is predominantly stabilized via electrostatic interactions and hydrogen bonding. In particular, D90 and D93 from CIB2 form salt bridges with K112 and K116 from TMC1, respectively (Fig. 3b). Additionally, E11 from CIB2 engages in a charge-charge interaction with K121 from TMC1 (Fig. 3b). The side chain of K107 from TMC1 participates in a cation-π interaction with F21 of CIB2 (Fig. 3c, d). Several hydrogen bonds further contribute to the binding affinity and specificity, including those between Q17 and T20 from CIB2 and K107 and K116 of TMC1 (Fig. 3e), as well as between D93 from CIB2 and M113 from TMC1 (Fig. 3e). Furthermore, the side chain of M113 from TMC1 insert into a hydrophobic pocket formed by I27, L30, F88, and V92 from CIB2, enhancing the stability of the complex assembly (Fig. 3f).
a Electrostatic potential surface analysis of CIB2 showing a negatively charged central pocket that corresponds to the TMC1 binding site. b Ribbon diagram showing the detailed electrostatic interactions between CIB2 and TMC1. In this drawing, the interface highlights the salt bridges between D90 and D93 from CIB2 with K112 and K116 from TMC1, respectively, and a charge-charge interaction between E11 from CIB2 and K121 from TMC1. Residues involved in the binding are shown in stick model. The salt bridges are shown as dotted lines. c, d Ribbon diagram showing a pair of π-cation interaction between K107 from TMC1 and F21 from CIB2. e Ribbon diagram showing the hydrogen bonding interactions between CIB2 and TMC1. In this drawing, the interface highlights several hydrogen bonds including Q17 and T20 from CIB2 with K107 from TMC1, and between D93 from CIB2 and M113 from TMC1. Residues involved in the binding are shown in stick model. The hydrogen bonds are shown as dotted lines. f Surface representation of CIB2 colored according to Eisenberg hydrophobicity scale. Ribbon-stick diagram showing that the key residues involved in hydrophobic interactions. CIB2 forms hydrophobic pocket and the side chain of TMC1 M113 is inserted into the hydrophobic pocket on CIB2, composed of I27, L30, F88, and V92, contributing to the complex’s stability. g The measured binding affinities between various mutations of CIB2 1-187 and TMC1CBD-1 based on ITC assays and comparison against CIB2 1-187 WT (wild-type) in binding with TMC1CBD-1 (left). The measured binding affinities between various. mutations of TMC1CBD-1 and the CIB2 1-187 based on ITC assays and comparison against TMC1CBD-1 WT in binding with CIB2 1-187 (right).
To assess the significance of key residues at the CIB2-TMC1CBD-1 interface, we conducted mutational studies and examined the impact on CIB2-TMC1CBD-1 binding using AGFC and ITC. In line with our structural findings, mutations that disrupted pivotal interactions resulted in weakened or nullified binding between CIB2 and TMC1CBD-1 (Fig. 3g). Substituting D93 from CIB2 with alanine remarkably reduced TMC1 binding (Fig. 3g, Supplementary Fig. 5a, g), while the D90R variant from CIB2 also significantly weakened the interaction (Fig. 3g, Supplementary Fig. 5b, h), highlighting the crucial roles of CIB2 D90 and D93. Conversely, the CIB2 E11R variant had a modest effect (Fig. 3g, Supplementary Fig. 5c, i). CIB2 Q17A and T20A double mutation led to over a 15-fold decrease in binding affinity (Fig. 3g, Supplementary Fig. 5d, j). For TMC1CBD-1, the K116A variant completely abolished binding (Fig. 3g, Supplementary Fig. 6a, f), the K112E variant significantly reduced binding (Fig. 3g, Supplementary Fig. 6b, g), and the K121E variant had a minor impact (Fig. 3g, Supplementary Fig. 6c, h). Additionally, ITC results showed that both two pairs of the reverse double point mutations (CIB2 D90K-TMC1 K112D and CIB2 D93K-TMC1 K116D) could not restore the binding affinity (Supplementary Fig. 7a–d). Circular dichroism spectroscopy showed that all the four mutations retained well-folded states (Supplementary Fig. 7e, f). Both the M113A variant from TMC1 and the F88Q/V92Q double mutation from CIB2 entirely eradicated the interaction (Fig. 3g, Supplementary Fig. 5e, k, Supplementary Fig. 6d, i), confirming the vital role of hydrophobic interactions in complex formation, in agreement with our previous mapping results (Fig. 1b). The F21Q mutation from CIB2 and K107A mutation from TMC1 variably reduced the interaction as expected (Fig. 3g, Supplementary Fig. 5f, l, Supplementary Fig. 6e, j). Together, these mutagenesis results underscore the pivotal roles of the interface residues observed in the CIB2-TMC1CBD-1 crystal structure.
High structural conservation of CIB family proteins across species
Sequence alignment has demonstrated a high degree of conservation among CIB2 proteins across species (Supplementary Fig. 8). Remarkably, essential interface residues in the human CIB2-TMC1CBD-1 complex are also present in the recently resolved CALM-1-TMC-1 complex of C. elegans, as determined by cryo-EM17. For instance, residues E11, D90, and D93 from human CIB2 are identical to E23, D104, and D107 from CALM-1 (Fig. 4a, b), playing a crucial role in the CALM-1-TMC-1 interface17. Structural alignment of human CIB2 with C. elegans CALM-1, based on backbone alpha carbon atoms, revealed a root mean square deviation (RMSD) of approximately 1.1 Å (Fig. 4b), suggesting a highly conserved mode of interaction between CIB proteins and TMC1 throughout evolution, potentially reflecting their essential physiological roles.
a Sequence alignment of human CIB2, human CIB3, and C. elegans CALM-1. Residues that are identical and highly similar are indicated in red and transparent boxes, respectively. The location of key residues for TMC1CBD-1 binding are indicated on the sequence. E23, D104, and D107 from CALM-1 are labeled with green triangles while E11, Q17, T20, F21, and D93 from CIB3 are labeled with blue triangles. Those residues play crucial roles in the CALM-1-TMC-1 interface or CIB3-TMC-1 interface. b Superposition of CIB2 (orange) and CALM-1 (cyan, PDB: 7USW) using backbone α -carbon atoms highlights structural conservation (RMSD = 1.1 Å). Calcium ions from CALM-1 structure are shown as cyan spheres and magnesium ions from CIB2 structure are shown as gray spheres. CIB2 residues for TMC1CBD-1 binding are shown as orange spheres, CALM-1 residues for TMC1 H1-H3 binding are shown as cyan spheres. c Superposition of CIB2 (orange) and CIB3 (green, PDB: 6WUD) using backbone α -carbon atoms highlights structural conservation (RMSD = 1.0 Å). Magnesium ions from CIB3 structure are shown as green spheres while magnesium ions from CIB2 structure are shown as gray spheres. CIB2 residues for TMC1CBD-1 binding are shown as orange spheres, CIB3 residues that conserved with CIB2 are shown as green spheres. d Structure alignment of CIB2-TMC1CBD-1 complex and CIB3-TMC1CBD-2 (PDB: 6WUD) complex. CIB2 is shown in orange, and TMC1CBD-1 is shown in light blue. CIB3 is shown in green, and TMC1CBD-2 is shown in pink. Magnesium ions from CIB3 structure are shown as green spheres and magnesium ions from CIB2 structure are shown as gray spheres. e Structure alignment of CIB2-TMC1CBD-1 complex and TMC-1 complex (PDB 7USW). CIB2 is shown in orange, TMC1CBD-1 in light blue, TMC-1 in green, and TMC1CBD-2 in pink. CALM-1 is displayed in yellow. Calcium ions from the CALM-1 structure are represented as yellow spheres, and magnesium ions from the CIB2 structure are shown as gray spheres. f Structure alignment of CIB2-TMC1CBD-1 complex and TMC-2 complex (PDB 8TKP). CIB2 is shown in orange, TMC1CBD-1 in light blue, TMC-2 in cyan, TMC-2CBD-2 in pink. CALM-1 is displayed in yellow. Calcium ions from the CALM-1 structure are represented as yellow spheres, and magnesium ions from the CIB2 structure are shown as gray spheres. g Co-IP analysis of the binding between full-length TMC1 and CIB2. HEK-293T cells co-expressing TMC1-GFP WT or TMC1-GFP variants and CIB2 followed by anti-Flag beads to immunoprecipitate and detected using GFP antibodies. Data are represented as the mean ± SEM (n = 3). ***p < 0.001; ****p < 0.0001 based on one-way ANOVA with Dunnett’s test.
A recent study has unveiled a novel CIB binding site in the first cytoplasmic loop between TM domains 2 and 3 of TMC1 with amino acids 298–359, named CBD-2 here (Fig. 1a), and elucidated the structure of the CIB3-TMC1CBD-2 complex15. From the sequence alignment data, residues E11, Q17, T20, F21, and D93 in CIB2 are entirely identical to those in CIB3 (Fig. 4a, c), underscoring their importance in the CIB-TMC1CBD-1 interface. Furthermore, structural analysis revealed even more pronounced conservation between the CIB2 and CIB3 proteins, with an RMSD of only 1.0 Å (Fig. 4c, d). The alignment indicates that TMC1CBD-1 interacts with the N-terminal region of CIB2, while TMC1CBD-2 can bind to the C-terminal region on the opposite direction simultaneously (Fig. 4d). These observations suggest that the two TMC1 binding sites on CIB2 are distinct and non-overlapping. This conclusion aligns with findings in C. elegans, where CALM-1 exhibits similar multifaceted binding characteristics17,18.
The structural comparison between the cryo-EM complexes of TMC-1 and TMC-2 reveals that the CIB2-TMC1 complex exhibits a high degree of structural conservation with both TMC1 and TMC2 across most regions (Fig. 4e, f). The backbone RMSD values, calculated by aligning 145 Cα atoms corresponding to CIB2 and CALM-1, are 1.19 Å for CIB2-TMC1 versus TMC-1 complex and 1.09 Å for CIB2-TMC1 versus TMC-2 complex, underscoring their conserved architecture. While CIB2 and CALM-1 share significant sequence and structural similarity, distinct spatial arrangements arise upon binding with metal ions. In the CIB2-TMC1 complex, the EF3 and EF4 domains of CIB2 are positioned closer together compared to the corresoponding domains of CALM-1 in the TMC-1 and TMC-2 complexes (Fig. 4e, f). This spatial rearrangement leads to a positional shift of approximately 4.5 Å in the TMC1CBD-1 region within the CIB2-TMC1 complex relative to its positioning in the TMC-1 and TMC-2 complexes. The binding interfaces of CIB2 and CALM-1 with TMC1CBD-1 exhibit near-identity, while the CALM-1–TMC1CBD-2 interface shows high similarity to the interface observed in the CIB3-TMC1 complex (Fig. 4d). Both CIB2 and CALM-1 interact with TMC1CBD-1 predominatly via the H1–H3 helices of TMC1, which adopt a paddle-like orientation, lying parallel to the membrane and embedding into CIB2 or CALM-1. The interaction between CALM-1 and TMC-1CBD-1 relies primarily on electrostatic forces. In contrast, the CIB2–TMC1CBD-1 interaction involves electrostatic, hydrophobic, hydrogen-bonding, and cation-π interactions, forming a complex interaction network. Our analysis precisely identified the amino acid pairs involved in each type of interaction. Using site-directed mutagenesis, we further validated the critical residues essential for the formation of the CIB2-TMC1CBD-1 complex, providing a detailed interaction mechanism. Additionally, CALM-1 engages TMC1CBD-2 via the cytoplasmic H5–H6 helices of TMC-1, predominantly through hydrophobic interactions. This interaction mode is consistent with the CIB3-TMC1 complex, further highlighting the conserved nature of these molecular interactions. These findings underscore both the conserved and species-specific adaptations of the interactions between CIB family proteins and TMC complexes, reflecting their evolutionary significance and mechanistic diversity.
Based on these studies, we next evaluated the binding between full-length TMC1 and CIB2 through co-immunoprecipitation (Co-IP) experiments. Specifically, we co-transfected GFP-tagged full-length TMC1 protein (either wild-type or variants) and 3xFlag-tagged CIB2 into HEK-293T cells. We utilized anti-Flag beads to immunoprecipitate the cell lysates and detected TMC1-GFP signals using GFP antibodies. These experiments were repeated in three independent batches. We observed robust binding when using the full-length wild-type TMC1 protein with CIB2 (Fig. 4g, Supplementary Fig. 9). Conversely, mutations at critical residues, including either TMC1 CBD-1 (M113A, K116A, or M113A and K116A double mutation), TMC1 CBD-2 (F318R, W321D, or F318R and W321D double mutation), or another potential binding region (K175A and E178A double mutation) in the TMC1 full-length protein, congruously dismissed the interaction with CIB2 (Fig. 4g, Supplementary Fig. 9). These results suggest that both TMC1 CBD-1 and TMC1 CBD-2 are crucial for a complete interaction with CIB2 under physiological conditions.
Calcium-dependent modulation of CIB2-TMC1 interactions
Given that CIB2 binds Ca2+ and undergoes conformational changes24,26, we evaluated the capability of Ca2+-bound CIB2 to interact with TMC1 using ITC assays. We observed a progressive enhancement in the CIB2-TMC1CBD-1 interaction with escalating concentrations of Ca2+ (Fig. 5a, b), in stark contrast to the Ca2+-free condition which exhibited a Kd of approximately 0.3 μM (Fig. 1d). Notably, this enhancement in binding affinity plateaued at a Ca²⁺ concentration of 1 mM, with no further increase beyond this concentration, as the affinity remained unchanged at the Ca²⁺ concentration of 3 mM (Fig. 5c). Given the distinct localization of TMC1CBD-1 and TMC1CBD-2 binding sites on opposing facets of CIB2, we probed whether the binding dynamics differed for the formation of these individual complexes.
a–c ITC based measurements of the binding affinities between CIB2 1-187 and TMC1CBD-1 under different calcium concentrations, including 0.5 mM Ca2+ (a) 1 mM Ca2+ (b) and 3 mM Ca2+ (c) showing Ca2+ elevates the interaction between CIB2 and TMC1CBD-1. d ITC-derived binding curves comparing the binding affinities between CIB2 1-187 and TMC1CBD-2 complex under the condition of Ca2+ free (dark red) or 10 μM Ca2+ (purple) or 0.5 mM Ca2+ (blue), showing Ca2+ is absolutely required for CIB2-TMC1CBD-2 interaction. e AGFC experiment revealed that no interaction is detected between CIB2 1-187 and TMC1CBD-2 in Ca2+ free condition. f AGFC experiment indicated that direct interaction exists between CIB2 1-187 and TMC1CBD-2 in 0.5 mM Ca2+ buffer condition. g AGFC experiments demonstrated that CIB2 1-187 could simultaneously interact with both TMC1CBD-1 and TMC1CBD-2 in 0.5 mM Ca2+. h Bijvoet difference map density, in green mesh, shows a lack of cation occupancy in EF hands 3 and 4. The D116, D120, D127, D157, D159, D161, and D168 side chains are labeled and represented in sticks. i, j ITC based measurements of the binding affinities between EF-hand double mutations of CIB2 1-187 and TMC1CBD-2 in 3 mM Ca2+ (i) and TMC1CBD-1 in 3 mM Ca2+ (j).
In a distinct contrast to the CIB2-TMC1CBD-1 interaction, no binding of CIB2 to TMC1CBD-2 was observed under Ca2+-free conditions (Fig. 5d, e). We then investigated CIB2-CBD2 interaction with multiple Ca2+ concentrations including 10 μM, 40 μM, 100 μM, 300 μM, 0.5 mM, and 3 mM via ITC experiments (Fig. 5d, Supplementary Fig. 10). It exhibited very weak binding between CIB2 and CBD-2 with a Kd over 100 μM with 10 μM or 40 μM Ca2+ (Supplementary Fig. 10a–b). Upon increasing the Ca2+ concentration to 100 μM, a strong interaction was noted (Supplementary Fig. 10c). Additionally, the ITC results showed an enhancement in the interaction between CIB2 and TMC1CBD-2 when the Ca2+ concentration increased from 300 µM to 3 mM (Supplementary Fig. 10d–f). Specifically, CIB2 exhibited a markedly high-affinity binding to TMC1CBD-2 with a Kd of approximately 0.4 μM when the Ca2+ concentration is 0.5 mM (Fig. 5d, Supplementary Fig. 10e). We further investigated whether Ca²⁺-bound CIB2 could simultaneously interact with both TMC1CBD-1 and TMC1CBD-2. A mixture of CIB2 with equimolar concentrations of TMC1CBD-1 and TMC1CBD-2 (70 μM each) in 0.5 mM Ca²⁺ resulted in the formation of a ternary complex, as evidenced by a new peak (red line) in the chromatography distinct from those individual 1:1 complex of CIB2 with either TMC1CBD-1 or TMC1CBD-2 (Fig. 5g). To ascertain the calcium dependency of these interactions, we employed a CIB2 double mutant (D127A/D168A) with impaired Ca²⁺ binding (Fig. 5h). This mutant displayed an inability to bind TMC1CBD-2 in the presence of 3 mM Ca²⁺ (Fig. 5i), and exhibited a reduced affinity for TMC1CBD-1 (Fig. 5j). These findings collectively underscore the criticality of Ca²⁺ in facilitating CIB2’s simultaneous engagement with both TMC1CBD-1 and TMC1CBD-2, highlighting the pivotal role of calcium in the molecular interaction dynamics of these proteins.
The CBD-1 and CBD-2 domains of hTMC1 display a significant degree of similarity to the corresponding amino acid sequences of hTMC2 CBD-1 (aa 150-200) and hTMC2 CBD-2 (aa 363-424) (Supplementary Fig. 11a). CIB2 also binds to TMC2CBD-1 with a Kd of approximately 0.6 μM in 0.5 mM Ca2+, showing a slightly stronger affinity compared to Ca2+-free condition (Supplementary Fig. 11b–c). TMC2CBD-2 showed weak interaction with CIB2 without Ca2+ (Supplementary Fig. 11d), and exhibited higher binding affinity to CIB2 in 0.5 mM Ca2+ (Supplementary Fig. 11e). Collectively, these findings demonstrated the Ca²⁺ regulation of CIB2’s interaction with both TMC2CBD-1 and TMC2CBD-2.
Deafness-related CIB2 mutations variably affect TMC1CBD-1 and TMC1CBD-2 binding
In light of the divergent binding specificities of CIB2 for TMC1CBD-1 and TMC1CBD-2, we further explored whether mutations in CIB2 associated with deafness variably influence its affinity for these two sites. We examined seven CIB2 mutations implicated in hearing loss, including E64D, R66W, F91S, C99W, Y115C, I123T, and R186W10,27,28 (Fig. 6a), which are conserved across human CIB2, human CIB3, and CIB2 orthologs (Supplementary Fig. 1b, Fig. 8). Notably, none of these mutations was located at the identified interfaces with TMC1CBD-1 and TMC1CBD-2. However, pull-down assays revealed a pronounced impact of these mutations on both TMC1CBD-1 and TMC1CBD-2 bindings. In particular, the F91S mutation in CIB2 almost entirely negated binding to TMC1CBD-1, while the C99W mutation significantly impaired TMC1CBD-1 binding, albeit to a lesser extent for other variants (Fig. 6b). Structurally, residue F91 in CIB2, situated proximal to the binding interface, engages in hydrophobic interactions with F34 and F95 (Fig. 6c). The substitution of F91 with serine, a hydrophilic residue, presumably disrupts the hydrophobic environment, consequently destabilizing CIB2’s conformation and diminishing its affinity for TMC1CBD-1.
a Structural properties of CIB2 and its pathogenetic variants are shown. Cartoon and surface representation are superposed. The N-terminal region and EF1 is colored light blue. EF2, and EF3 are colored green and orange, and the C-terminal region and EF4 is colored pink. Residues affected by pathogenic missense mutations are colored according to the EF-hand domain in which they are located, and magnesium ions are represented by gray spheres. The area where F91 is located is marked with a black border and the area where I123 is located is marked with a blue border. b GST pull-down assays showed that the F91S and C99W variants of CIB2 significantly decrease the binding with GST-TMC1CBD-1. Data are represented as the mean ± SEM (n = 3). **p < 0.01; ***p < 0.001 based on one-way ANOVA with Dunnett’s test. c The CIB2 structure model highlights residue F91, which forms hydrophobic interactions and π-π interactions with residues F34 (light blue) and F95 (green). d GST pull-down assays showing that the all the variants of CIB2 decrease the binding with GST-TMC1CBD-2. Data are represented as the mean ± SEM (n = 3). ***p < 0.001; ****p < 0.0001 based on one-way ANOVA with Dunnett’s test. e The CIB2 structure model highlights residue I123, which forms hydrophobic interactions with residues Y115 (orange) and F169 (pink) and the main chain of D116 (orange). f ITC-based measurements of the binding affinities of CBD-1 or CBD-2 and various CIB2 deafness-related mutants including E64D, R66W, F91S, C99W, Y115C, I123T, and R186W.
In contrast, the I123T mutation, which had little effect on TMC1CBD-1 binding, substantially hindered TMC1CBD-2 binding in the presence of 0.5 mM Ca2+ (Fig. 6d). Other mutations, including E64D, C99W, and Y115C also significantly reduced CIB2’s binding to TMC1CBD-2 (Fig. 6d). R66W and R186W mutations exhibited lesser impacts on both TMC1CBD-1 and TMC1CBD-2 binding (Fig. 6b, d). In the CIB2 structure, the residue I123, located within the EF3 loop, forms robust hydrophobic interactions with F169 and Y115, further stabilized by the mainchain of D116 (Fig. 6e). The introduction of a hydrophilic threonine at this position likely disrupts this hydrophobic milieu. Such a conformational shift could potentially alter the orientation of EF3 calcium ligands, thereby diminishing calcium affinity and, by extension, TMC1CBD-2 binding. A similar mechanism underlies the compromised TMC1CBD-2 binding observed with the Y115C mutant. These findings provide a molecular basis for previous observations that the F91S and I123T mutations in CIB2 markedly reduce TMC1/2 binding and impair mechanotransduction15. Furthermore, the results obtained from ITC experiments are consistent with those derived from the pull-down assays (Fig. 6f, Supplementary Fig. 12, Supplementary Fig. 13). CD results showed that most of the mutants retain the typical helical folding, but the folding of the F91S mutant appears to be somewhat affected (Supplementary Fig. 14).
In summary, our study demonstrates that specific mutations linked to deafness in CIB2 can differentially disrupt its binding to TMC1CBD-1 (notably F91S) or TMC1CBD-2 (predominantly I123T). Several of these mutations, such as I123T and Y115C, appear to adversely affect TMC1CBD-2 binding through impaired calcium sensing capability (Fig. 6e).
Discussion
The mechanoelectrical transduction (MET) channel complex in the stereocilia of mammalian hair cells plays a pivotal role in auditory perception. However, the molecular interactions between the TMC1 and its critical auxiliary subunits CIB2/CIB3 remain largely unexplored. In this study, we elucidated the CIB2-TMC1 interaction by resolving the structure of the CIB2-TMC1CBD-1 complex and pinpointing essential interface residues. Significantly, this interaction is modulated by calcium, evidenced by the increased affinity of Ca2+-bound CIB2 for TMC1CBD-1, while the binding between CIB2 and TMC1CBD-2 is totally calcium-dependent. Consequently, CIB2 can simultaneously interact with both the TMC1CBD-1 and TMC1CBD-2 sites on TMC1 in the presence of Ca2+. We also discovered that certain mutations in CIB2 linked to deafness variably impair or completely disrupt these interactions, presumably due to disrupting the calcium-binding site on EF hand 3. These finding underscore the critical role of Ca2+ in regulating the assembly and functionality of the MET complex.
The interaction mechanisms of CIB2 with TMC1 bear resemblance to the interaction between calmodulin (CaM) and calcium channels, where CaM serves as a classic calcium-sensing protein modulating various ion channels29,30. Our findings indicate that TMC1 contains two CIB2 binding sites. At baseline calcium levels, apo-CIB2 binds to TMC1CBD-1. However, with increased Ca2+ levels, Ca2+-CIB2 binds to the opposite side CBD-2, effectively linking both TMC1’s CBD-1 and CBD-2 domains. This mechanism parallels the dual CaM binding domains in L-type voltage-gated Cav1.2 and Cav1.3 channels, located in the C-terminal IQ-motif and the N-terminal NSCaTE. Under resting conditions, apo-CaM attaches to the IQ-motif. Channel activation and subsequent Ca2+ influx leads to Ca2+-CaM binding to NSCaTE, triggering a conformational change that shuts the Cav channel, thus regulating further Ca2+ entry31,32. Given these analogous binding properties, we propose that Ca2+-CIB2 may similarly induce a conformational shift in TMC1, resulting in channel closure and inactivation of the MET complex. Several related structures have been determined by cryo-EM and deepen the understanding of CIB-TMC MET complex17,18. The structural analysis reveals the proximity of the CALM-1 Ca²⁺ binding sites to the interface between CALM-1 and TMC-1 in C. elegans, thereby highlighting the roles of both Ca²⁺ and CALM-1 in shaping the conformation of TMC-117. While TMC-1 or TMC-2 MET complexes exhibit a closed putative ion-conduction pathway, its open conformation remains unidentified.
In resting conditions, MET channels in cochlear hair cells are not fully closed, allowing a baseline influx of Ca2+ even without auditory stimuli33,34,35. This state sets the channel’s position along the activation curve, priming it for maximum sensitivity to mechanical stimulation. The opening probability (Po) of transduction channels at rest is influenced by external and internal Ca2+ concentrations36,37. Supporting our hypothesis, recent study show that the resting Po in OHCs from Tmc1dn/dn;Cib2R186W/+ mutants is higher in high BAPTA concentrations, with MET currents significantly reduced at negative potentials when external Ca2+ levels are increased15. Additionally, the structure of the TMC1 complex from C. elegans in the presence of Ca2+-loaded CALM-1 reveals a closed conformation17, further substantiating our hypothesis.
Calcium sensor proteins play a vital role in modulating ion channel functions through calcium-mediated interactions. For instance, the neuronal calcium sensor KChIPs interact with the N-terminus of Kv4 potassium channels, influencing their gating, surface expression, and assembly38. Notably, KChIP1 variants incapable of calcium binding do not significantly alter the amplitude or kinetics of Kv4.3 currents compared to native KChIP139. In the realm of photoreceptors, cyclic nucleotide-gated (CNG) channels exhibit optimal open probability at lower calcium concentrations40. The binding of Ca2+-calmodulin to CNGB1 is instrumental in the calcium-dependent desensitization of retinal rod CNG channels, a process crucial for light adaptation. Disturbances in this calcium-dependent mechanism of CNG channel function are linked to inherited blindness41. These instances underscore the fundamental role of calcium sensor proteins, akin to CIB2, in orchestrating ion channel function via calcium-centric interactions.
Numerous deafness-linked CIB2 mutations have been identified27, but their impact on CIB2 binding to TMC1CBD-1 and TMC1CBD-2 are unclear. Our investigation of seven CIB2 mutants revealed that two mutations (F91S, C99W) significantly impair CIB2-TMC1CBD-1 binding, while four others (E64D, C99W, Y115C, I123T) notably reduce CIB2-TMC1CBD-2 binding (Fig. 6). The Y115C and I123T mutations likely alter the structure of CIB2’s EF-hand 3, diminishing its calcium-binding capacity. Additionally, the E64D mutant shows decreased calcium affinity and fails to attain a native conformation even at high calcium levels24. Our research indicates that numerous mutations linked to deafness compromise calcium binding in CIB2, suggesting that calcium-dependent CIB2-TMC1 interactions are essential for auditory function. This breakthrough offers promising avenues for developing therapeutic strategies aimed at rectifying calcium-binding anomalies associated with CIB2-related deafness.
While further investigation is needed to fully understand the calcium-dependent effects on the MET channel, our findings lay the groundwork for the molecular and structural understanding of CIB2-TMC1CBD-1 complex formation. They also highlight the significant role of calcium in the assembly of the MET channel. Future functional studies focusing on calcium-bound CIB2 are crucial to determine whether CIB2 influences the mechanotransduction process.
Materials and Methods
Constructs, protein expression and purification
The coding sequences of the human CIB2 (UniProt: O7538), mouse CIB3 (UniProt: A0A5F8MPX9), and human TMC1CBD-1 or TMC1CBD-2 (UniProt: Q8TDI8) constructs were PCR amplified from cDNA libraries. The mouse CIB1 (UniProt: Q9Z0F4) and mouse CIB4 (UniProt: Q9D9N5) constructs were generous gifts from Dr. Qing Lu (Shanghai Jiaotong University). The GFP-N1 tagged full-length human TMC1 constructs were generous gifts from Dr. Yiquan Tang (Fudan University). All of the protein constructs were cloned into a modified pET32a vector for protein expression and confirmed by DNA sequencing. The fusion constructs used for crystal screening were made by two-step PCR with a linker sequence of “GSLVPRGS” between TMC1 and CIB2. In particular, the consult for solving the crystal structure is made through fusing the TMC1CBD-1 (residues 86–136) at the N-terminal of CIB2 full-length (residues 1–187) with the above linker sequence. The various mutations or short fragments of CIB2 and TMC1 were generated by standard PCR-based methods and confirmed by DNA sequencing. All the proteins were expressed in Escherichia coli BL21 (DE3) cells. The N-terminal thioredxin-His6-tagged proteins were purified using Ni-NTA agarose affinity column followed by size-exclusion chromatography (Superdex 200 column, GE Healthcare) in the buffer containing 50 mM Tris (pH 7.8), 100 mM NaCl, 1 mM DTT, and either 1 mM EDTA, or 0.5/1/3 mM CaCl2. For crystal screening proteins, the thioredxin-His6 tag was removed by incubation with HRV 3 C protease at 4 °C overnight and separated by size-exclusion chromatography.
Isothermal titration calorimetry assay
Isothermal titration calorimetry (ITC) measurements were carried out on a VP-ITC MicroCal calorimeter (Malvern) at 25 °C. All proteins were dissolved in the buffer containing 50 mM Tris (pH 7.8), 100 mM NaCl, 1 mM DTT, and either 1 mM EDTA, or 0.5/1/3 mM CaCl2. TMC1 proteins (200 μM) were loaded into the syringe, and CIB2 proteins (20 μM) were loaded in the cell. Each titration point was performed by injecting a 10 μl aliquot of syringe protein into the cell at a time interval of 180 s to ensure that the titration peak returned to the baseline. The titration data were analyzed using the program Origin 7.0 (MicroCal) and fitted by the one-site binding model. All the ITC experiments have been repeated more than twice.
AGFC assay
Analytical gel filtration chromatography was carried out on an AKTA Pure system (GE Healthcare). Recombinant proteins with N-terminal His6-tag were concentrated to 70 µM and loaded onto a Superdex200 increase 10/300 GL column (GE Healthcare) equilibrated with the assay buffer (50 mM Tris (pH 7.8), 100 mM NaCl, 1 mM DTT, and either 1 mM EDTA, or 0.5 mM CaCl2.). All the graphs here were drawn by GraphPad Prism 5.
AGFC coupled with static light scattering
The analysis was performed on an AKTA Pure system (GE Healthcare) coupled with a static light scattering detector (miniDawn, Wyatt) and a differential refractive index detector (Optilab, Wyatt). Protein samples (concentration of 70 μM for CIB2 and TMC1) were filtered and loaded into a Superdex 200 increase column. Data were analyzed with ASTRA7 (Wyatt).
GST pull-down assay
For GST pull-down assays, GST-tagged TMC1CBD-1 protein was purified in the buffer containing 50 mM Tris, 100 mM NaCl, 1 mM EDTA, and 1 mM DTT at pH 7.8, and GST-tagged TMC1CBD-2 was purified in the buffer containing 50 mM Tris, 100 mM NaCl, 0.5 mM CaCl2, and 1 mM DTT at pH 7.8, detected by SDS-PAGE and Coomassie blue staining. The purified CIB2 mutant proteins (E64D, R66W, F91S, C99W, Y115C, I123T, R186W) (60 μM) were incubated with 20 μM of distinct GST, GST-TMC1CBD-1, or GST-TMC1CBD-2 for 2 h at 4 °C. The 30 μL GSH-sepharose 4B slurry beads in the protein purification buffer were then incubated with the protein mixture for 1 h at 4 °C. After three times wash with the protein purification buffer, the captured proteins were eluted by 20 μl SDS-PAGE loading dye and detected by coomassie blue staining in the SDS-PAGE gels. These experiments were repeated in three independent batches.
Co-immunoprecipitation and western blotting
HEK-293T cells were transfected with plasmids using polyethylenimine (PEI). 48 hours post-transfection, cells were washed with fresh PBS and lysed using RIPA buffer containing 150 mM NaCl, 50 mM Tris (pH 7.4), 1% Triton X-100, 1% Sodium Deoxycholate, 0.1% Sodium Dodecyl Sulfate (SDS) and a protease inhibitor cocktail. The lysates were then rotated for 30 min at 4 °C, followed by centrifugation at 14,000 rpm for 30 min at 4 °C. Subsequently, 10% of the lysate was reserved as an input control. The remaining lysate underwent overnight immunoprecipitation at 4 °C using 20 μL of anti-DYKDDDDK Affinity Beads (Smart Lifesciences Cat# SA042001). Post-immunoprecipitation, the beads were washed three times with 1x PBST (1x PBS with 0.1% Tween-20). Immunoprecipitated proteins were then eluted using 2x SDS-PAGE sample loading buffer and resolved on SDS-PAGE before being transferred to PVDF membranes (Sigma). These membranes were blocked for 1 hour with 5% skim milk powder in 1x PBST, then incubated overnight at 4 °C with primary antibodies (1:1000 dilution each for mouse anti-GFP (Proteintech, Cat# 66002-1-Ig), mouse anti-FLAG (Proteintech, 66008-4-Ig), or rabbit anti-α-tubulin(Proteintech, 11224-1-AP)). Following primary antibody incubation, the membranes were washed three times with 1x PBST and incubated for 1 hour at room temperature with secondary antibodies (1:10000 for goat anti-mouse IgG-HRP (Absin, Abs20001) or goat anti-rabbit IgG-HRP(Absin, Abs20002)) diluted in 5% milk in 1x PBST. After three additional PBST washes, the membranes were developed using BeyoECL (Beyotime) and imaged on a Tanon 5200 system.
Circular Dichroism measurements
The CD spectra of the proteins were acquired on a JASCO J-1700 CD Spectrometer at the room temperature using a cell path length of 0.5 mm. Each spectrum was collected with three scans spanning a spectral window of 190–260 nm. CIB2 WT and mutant proteins (E64D, R66W, F91S, C99W, Y115C, I123T, and R186W) were purified and diluted into 0.2 mg/mL in a buffer containing 25 mM Tris pH 7.8, 50 mM NaCl, 0.5 mM EDTA and 0.5 mM DTT.
Protein crystallization and structure determination
Crystals of the CIB2-TMC1 complex were obtained by the hanging drop vapor diffusion method at 16 °C under the condition of 25% (w/v) Polyethylene glycol 3350, 0.1 M Tris (pH 8.5), 0.2 M Magnesium chloride hexahydrate. 25% glycerol was added as the cryo-protectant before diffraction data collection. The diffraction data were collected at Shanghai Synchrotron Radiation Facility and processed using HKL2000. The structure was solved by PHASER software42 using molecular replacement method with the structure of CIB3 (PDB: 6WU5) as the search model. The model of TMC1 was manually built according to the difference electron-density map in COOT43. Further model modifications and refinements were repeated alternatively using COOT software and PHENIX software. The final model was validated using MolProbity44 and the statistics are shown in Table 1. The structure figures were made using PyMol software (https://www.pymol.org).
Sequence alignment analysis
The sequence of the human CIB2 and human TMC1/2 protein was obtained from the UniProt database, and this sequence was submitted to the NCBI-BLAST to search for homologs. CIB and TMC homologous sequences were selected and aligned using multiple sequence alignment (https://www.genome.jp/tools-bin/clustalw) with default parameters. The ESpript 3.0 software was used to generate the color-coded version of the multiple sequence alignment (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgit). Phylogenetic tree of CIB1-4 was made by the software of MEGA1145.
Statistics and reproducibility
For both the pull-down and co-immunoprecipitation (Co-IP) analyses, we performed at least three independent experiments. Data were statistically analyzed using one-way ANOVA with Dunnett’s test to compare test samples to the control, and results are presented as mean ± SEM. The threshold for statistical significance was set at p < 0.05 for all tests. Data analysis was conducted using ImageJ and GraphPad Prism version 9.5.0. Source data are included with this paper.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary information. Source data for the figures can be found in the Supplementary Data 1. The atomic coordinates of the CIB2-TMC1 complex have been deposited to the Protein Data Bank under the accession code: 8XOQ.
References
Tilney, L. G., Tilney, M. S. & DeRosier, D. J. Actin Filaments, Stereocilia, and Hair Cells: How Cells Count and Measure. Annu. Rev. Cell Biol. 8, 257–274 (1992).
Pan, B. et al. TMC1 and TMC2 Are Components of the Mechanotransduction Channel in Hair Cells of the Mammalian Inner Ear. Neuron 79, 504–515 (2013).
Kurima, K. et al. TMC1 and TMC2 Localize at the Site of Mechanotransduction in Mammalian Inner Ear Hair Cell Stereocilia. Cell Rep. 12, 1606–1617 (2015).
Pan, X. Q. & Yan, Z. Q. Discovery of Touch Receptor NOMPC and Hearing Receptor TMC. Prog. Biochem. Biophys.48, 1398–1403 (2021).
Fettiplace, R. & Kim, K. X. The physiology of mechanoelectrical transduction channels in hearing. Physiol. Rev. 94, 951–986 (2014).
Pan, B. et al. TMC1 Forms the Pore of Mechanosensory Transduction Channels in Vertebrate Inner Ear Hair Cells. Neuron 99, 736–753.e736 (2018).
Jia, Y. et al. TMC1 and TMC2 Proteins Are Pore-Forming Subunits of Mechanosensitive Ion Channels. Neuron 105, 310 (2020).
Beurg, M., Barlow, A., Furness, D. N. & Fettiplace, R. A Tmc1 mutation reduces calcium permeability and expression of mechanoelectrical transduction channels in cochlear hair cells. Proc. Natl. Acad. Sci. 116, 20743–20749 (2019).
Giese, A. P. J. et al. CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cells. Nat. Commun. 8, 43 (2017).
Riazuddin, S. et al. Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48. Nat. Genet. 44, 1265–1271 (2012).
Dal Cortivo, G. et al. Oligomeric state, hydrodynamic properties and target recognition of human Calcium and Integrin Binding protein 2 (CIB2). Sci. Rep. 9, 15058 (2019).
Tang, Y.-Q. et al. Ankyrin Is An Intracellular Tether for TMC Mechanotransduction Channels. Neuron 107, 112 (2020).
Giese, A. P. J., et al. Complexes of vertebrate TMC1/2 and CIB2/3 proteins form hair-cell mechanotransduction cation channels. bioRxiv, 2023.2005.2026.542533. https://doi.org/10.1101/2023.05.26.542533. (2024).
Dal Cortivo, G. & Dell’Orco, D. Calcium- and Integrin-Binding Protein 2 (CIB2) in Physiology and Disease: Bright and Dark Sides. Int. J. Mol. Sci. 23, 3552 (2022).
Liang, X. et al. CIB2 and CIB3 are auxiliary subunits of the mechanotransduction channel of hair cells. Neuron 109, 2131–2149.e2115 (2021).
Lee, J. H. et al. The Piezo channel is a mechano-sensitive complex component in the mammalian inner ear hair cell. Nat. Commun. 15, 526 (2024).
Jeong, H. et al. Structures of the TMC-1 complex illuminate mechanosensory transduction. Nature 610, 796–803 (2022).
Clark, S., Jeong, H., Posert, R., Goehring, A. & Gouaux, E. The structure of the Caenorhabditis elegans TMC-2 complex suggests roles of lipid-mediated subunit contacts in mechanosensory transduction. Proc. Natl. Acad. Sci. USA 121, e2314096121 (2024).
Wang, X., Li, G., Liu, J., Liu, J. & Xu, X. Z. S. TMC-1 Mediates Alkaline Sensation in C. elegans through Nociceptive Neurons. Neuron 91, 146–154 (2016).
Yue, X. et al. TMC Proteins Modulate Egg Laying and Membrane Excitability through a Background Leak Conductance in&IT C. elegans&IT. Neuron 97, 571 (2018).
Gentry, H. R. et al. Structural and biochemical characterization of CIB1 delineates a new family of EF-hand-containing proteins. J. Biol. Chem. 280, 8407–8415 (2005).
Lepšík, M. & Field, M. J. Binding of Calcium and Other Metal Ions to the EF-Hand Loops of Calmodulin Studied by Quantum Chemical Calculations and Molecular Dynamics Simulations. J. Phys. Chem. B 111, 10012–10022 (2007).
Tang, S. & Yang, J. J. Magnesium Binding Sites in Proteins. In Encyclopedia of Metalloproteins, R. H. Kretsinger, V. N. Uversky, and E. A. Permyakov, eds. (Springer New York), pp. 1243–1250. https://doi.org/10.1007/978-1-4614-1533-6_257 (2013).
Vallone, R., Dal Cortivo, G., D’Onofrio, M. & Dell’Orco, D. Preferential Binding of Mg2+ Over Ca2+ to CIB2 Triggers an Allosteric Switch Impaired in Usher Syndrome Type 1J. Front. Mol. Neurosci. 11, 274 (2018).
Grabarek, Z. Insights into modulation of calcium signaling by magnesium in calmodulin, troponin C and related EF-hand proteins. Biochimica et. Biophysica Acta (BBA) - Mol. Cell Res. 1813, 913–921 (2011).
Blazejczyk, M. et al. Biochemical characterization and expression analysis of a novel EF-hand Ca2+ binding protein calmyrin2 (Cib2) in brain indicates its function in NMDA receptor mediated Ca2+ signaling. Arch. Biochem Biophys. 487, 66–78 (2009).
Booth, K. T. et al. Variants in CIB2 cause DFNB48 and not USH1J. Clin. Genet. 93, 812–821 (2018).
Patel, K. et al. A Novel C-Terminal CIB2 (Calcium and Integrin Binding Protein 2) Mutation Associated with Non-Syndromic Hearing Loss in a Hispanic Family. PLOS ONE 10, e0133082 (2015).
Kovalevskaya, N. V. et al. Structural analysis of calmodulin binding to ion channels demonstrates the role of its plasticity in regulation. Pflug. Arch. 465, 1507–1519 (2013).
Villalobo, A., Ishida, H., Vogel, H. J. & Berchtold, M. W. Calmodulin as a protein linker and a regulator of adaptor/scaffold proteins. Biochim Biophys. Acta Mol. Cell Res. 1865, 507–521 (2018).
Ivanina, T., Blumenstein, Y., Shistik, E., Barzilai, R. & Dascal, N. Modulation of L-type Ca2+ channels by gbeta gamma and calmodulin via interactions with N and C termini of alpha 1C. J. Biol. Chem. 275, 39846–39854 (2000).
Liu, Z. & Vogel, H. J. Structural basis for the regulation of L-type voltage-gated calcium channels: interactions between the N-terminal cytoplasmic domain and Ca(2+)-calmodulin. Front Mol. Neurosci. 5, 38 (2012).
Beurg, M., Nam, J.-H., Chen, Q. & Fettiplace, R. Calcium Balance and Mechanotransduction in Rat Cochlear Hair Cells. J. Neurophysiol. 104, 18–34 (2010).
Corns, L. F., Johnson, S. L., Kros, C. J. & Marcotti, W. Calcium entry into stereocilia drives adaptation of the mechanoelectrical transducer current of mammalian cochlear hair cells. Proc. Natl. Acad. Sci. 111, 14918–14923 (2014).
Johnson, S. L., Beurg, M., Marcotti, W. & Fettiplace, R. Prestin-Driven Cochlear Amplification Is Not Limited by the Outer Hair Cell Membrane Time Constant. Neuron 70, 1143–1154 (2011).
Fettiplace, R. Hair Cell Transduction, Tuning, and Synaptic Transmission in the Mammalian Cochlea. In Comprehensive Physiology, pp. 1197–1227. https://doi.org/10.1002/cphy.c160049 (2017).
Ó Maoiléidigh, D. & Ricci, A. J. A Bundle of Mechanisms: Inner-Ear Hair-Cell Mechanotransduction. Trends Neurosci. 42, 221–236 (2019).
Wang, H. et al. Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP subunits. Nat. Neurosci. 10, 32–39 (2007).
Pioletti, M., Findeisen, F., Hura, G. L. & Minor, D. L. Jr. Three-dimensional structure of the KChIP1-Kv4.3 T1 complex reveals a cross-shaped octamer. Nat. Struct. Mol. Biol. 13, 987–995 (2006).
Gray-Keller, M. P. & Detwiler, P. B. The calcium feedback signal in the phototransduction cascade of vertebrate rods. Neuron 13, 849–861 (1994).
Bej, A. & Ames, J. B. Retinal Cyclic Nucleotide-Gated Channel Regulation by Calmodulin. Int. J. Mol. Sci. 23, 14143 (2022).
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486–501 (2010).
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr 66, 12–21 (2010).
Tamura, K., Stecher, G. & Kumar, S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol. Biol. Evol. 38, 3022–3027 (2021).
Karplus, P. A. & Diederichs, K. Linking crystallographic model and data quality. Science 336, 1030–1033 (2012).
Acknowledgements
We thank beamlines BL18U1, BL19U1, and BL02U1 at Shanghai Synchrotron Radiation Facility (SSRF, China) for X-ray beam time. We thank Dr. Yiquan Tang from Fudan University for sharing the plasmids and helpful discussion. This work was supported by grants from the National Natural Science Foundation of China (22122703, 32100764, 32170767, 32470808, 91953110), the Ministry of Science and Technology of the People’s Republic of China (2019YFA0508402), the Major Frontier Research Project of the University of Science and Technology of China (LS9100000002), the Center for Advanced Interdisciplinary Science and Biomedicine of IHM (QYPY20220014), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB0490000), the Fundamental Research Funds for the Central Universities (WK9100000029), University of Science and Technology of China Research Funds of Double First-Class Initiative (YD9100002006).
Author information
Authors and Affiliations
Contributions
Y.L. and C.W. designed the experiments. Y.L., J.C., W.J., and J.Y. performed the experiments. J.C. and X.Z. determined the crystal structure. All authors analyzed the data. Y.L. and C.W. wrote the manuscript. All authors approved the final version of the manuscript. C.W. coordinated the project.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Communications Biology thanks Ebenezer Yamoah and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editors: Janesh Kumar and Laura Rodríguez Pérez.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Li, Y., Chen, J., Jiang, W. et al. Structural insights into calcium-dependent CIB2-TMC1 interaction in hair cell mechanotransduction. Commun Biol 8, 306 (2025). https://doi.org/10.1038/s42003-025-07761-1
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s42003-025-07761-1
This article is cited by
-
Genetic and clinical aspects of TMC1-related hearing loss in Iranian families: identification of two novel variants
Molecular Biology Reports (2026)








